Agency Business briefs

Share this article:
Compass Healthcare Communications has changed its name to Compass Healthcare Marketers. The name change, said president/CEO Peter Nalen, is meant to “reflect how we operate and how our clients view us—as their marketing partners.”

GSW Worldwide refreshed its website (www.gsw-w.com) with a new blog called Brand Liberators. The redesigned site features a 3-D character collage with movable elements that click through to video interviews, with testimonials, client work, capabilities and offerings. It's meant to “show what it means to truly live our brand,” said Phil Deschamps, president and CEO of the firm.

LyonHeart named Tim McCord EVP, chief digital innovation officer. McCord, previously an industry consultant who has worked for many Omnicom shops, will report directly to chairman and CEO Anne Devereux.

Bayard Advertising Agency was named agency of record for recruitment advertising by Cancer Treatment Centers of America. The agency is tasked with handling recruitment marketing and media for CTCA and “further developing and spreading its uplifting, compassionate brand message.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?